Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants
Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants
Active, not recruiting · NCT05501717 · Registry updated 2026-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety, PK/PD, and Immunogenicity Study of SC ALXN2030 in Healthy Participants | Healthy | Active, not recruiting | Phase 1 | 2026-04-09 | NCT05501717 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alexion Pharmaceuticals, Inc. | 48 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||